ACCELERON PHARMA INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ACCELERON PHARMA INC has filed 808 SEC EDGAR filings since 17 Feb 2004

SEC filing history

Showing 376-400 of 799 matching filings.

Per page
25
Current page
16
4

FORM 4 -

Filing date
04 Jan 2017
Reporting date
03 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Jan 2017
Reporting date
30 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
23 Dec 2016
Reporting date
22 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Dec 2016
Reporting date
21 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Dec 2016
Reporting date
07 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Dec 2016
Reporting date
07 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36065

8-K

Filing date
07 Dec 2016
Reporting date
04 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Dec 2016
Reporting date
01 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
05 Dec 2016
Reporting date
01 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2016
Reporting date
17 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Nov 2016
Reporting date
16 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
14 Nov 2016
Reporting date
09 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36065

8-K

Filing date
03 Nov 2016
Reporting date
03 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
11 Oct 2016
Reporting date
06 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Oct 2016
Reporting date
30 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36065

8-K

Filing date
27 Sep 2016
Reporting date
23 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
23 Sep 2016
Reporting date
21 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
13 Sep 2016
Reporting date
12 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36065

8-K

Filing date
12 Sep 2016
Reporting date
09 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
11 Aug 2016
Reporting date
10 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-190417

CT ORDER filing

Filing date
08 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36065

8-K

Filing date
04 Aug 2016
Reporting date
04 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
25 Jul 2016
Reporting date
25 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .